Latest Breaking News On - Darren opland - Page 1 : vimarsana.com

Axsome Therapeutics to Participate in Upcoming Investor Conferences

Axsome Therapeutics to Participate in Upcoming Investor Conferences
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

New-york
United-states
Miami-beach
Florida
Chicago
Illinois
Herriot-tabuteau
William-blair
Mark-jacobson
Darren-opland
Goldman-sachs
Loews-chicago-hotel

Axsome Therapeutics Highlights Data on Solriamfetol Demonstrating Improvement in Cognitive Function in Patients with Obstructive Sleep Apnea or Narcolepsy at SLEEP 2024

Axsome Therapeutics, Inc. , a biopharmaceutical company developing and delivering novel therapies for the management of central nervous system (CNS) disorders, today announced five presentations, including two featured oral plenary presentations, on.

Houston
Texas
United-states
New-york
Germany
Herdecke
Nordrhein-westfalen
American
Hans-van-dongen
Mark-jacobson
Darren-opland
Michael-thorpy

Axsome Therapeutics Presents Data from Multiple Programs at the 2024 American Society of ...

NEW YORK, May 28, 2024 (GLOBE NEWSWIRE) Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing and delivering novel therapies for the management of central nervous system (CNS) disorders,

New-york
United-states
Florida
Miami-beach
Toronto
Ontario
Canada
American
Roger-mcintyre
Jeffrey-cummings
Harryl-smith
Andrew-muzyk

Axsome Therapeutics to Present at Upcoming Investor Conferences

Axsome Therapeutics to Present at Upcoming Investor Conferences
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United-states
Nevada
New-york
Las-vegas
America
Darren-opland
Mark-jacobson
Herriot-tabuteau
Encore-hotel-in-las-vegas
World-trade-center
Nasdaq
Drug-administration

Axsome Therapeutics, Inc. (NASDAQ:AXSM) Q1 2024 Earnings Call Transcript

Axsome Therapeutics, Inc. (NASDAQ:AXSM) Q1 2024 Earnings Call Transcript
yahoo.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from yahoo.com Daily Mail and Mail on Sunday newspapers.

Darren-opland
Nick-pizzie
Change-healthcare

Axsome Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update

Axsome Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.

Mansfield
Nunavut
Canada
New-york
United-states
Darren-opland
Herriot-tabuteau
Mark-jacobson
Development-pipeline
Company-new-drug-application
Corporate-communications
Drug-administration

Axsome Therapeutics (AXSM) Q1 2024 Earnings Call Transcript

AXSM earnings call for the period ending March 31, 2024.

Darren-opland
Herriot-tabuteau
Marc-goodman-leerink
Jason-gerberry
Nick-pizzie
Mark-jacobson
David-amsellem-piper-sandler
Ram-selvaraju
Vikram-purohit
Joel-beatty
Charles-duncan

Axsome Therapeutics to Report First Quarter 2024 Financial Results on May 6

NEW YORK, April 10, 2024 Axsome Therapeutics, Inc. , a biopharmaceutical company developing and delivering novel therapies for the management of central nervous system disorders, today.

New-york
United-states
Darren-opland
Mark-jacobson
Drug-administration
Axsome-therapeutics-inc
World-trade-center
Nasdaq
Corporate-communications
Axsome-therapeutics
Markets

Axsome Therapeutics Initiates ENGAGE Phase 3 Trial of Solriamfetol for the Treatment of Binge Eating Disorder

NEW YORK, April 01, 2024 Axsome Therapeutics, Inc. , a biopharmaceutical company developing and delivering novel therapies for the management of central nervous system disorders, announced the.

New-york
United-states
American
Darren-opland
Mark-jacobson
Nasdaq
Drug-administration
Axsome-therapeutics-inc
American-psychiatric-association
World-trade-center
Corporate-communications
National-comorbidity-survey-replication

Axsome Therapeutics Announces Results of CRESCENDO Narcolepsy Patient Survey Demonstrating Unmet Needs in Treated Narcolepsy Type 1 Patients

77% of narcolepsy type 1 patients continue to experience cataplexy attacks despite being treated 64% of narcolepsy type 1 patients continue to experience excessive daytime sleepiness, as assessed.

United-states
United-kingdom
Philadelphia
Pennsylvania
New-york
British
Karl-doghramji
Darren-opland
Mark-jacobson
Nasdaq
Axsome-therapeutics-inc
Narcolepsy-network